Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by Ragard John Phillip. Director active across 1 company, notably Aspira Women's Health Inc.. Cumulatively, 5 filings have been logged. Activity tracked since 30 September 2024. The latest transaction was filed on 4 June 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Ragard John Phillip is a declarant linked to Aspira Women's Health Inc. (XNAS), where he is Director. He has 4 filings in total, and the sampled recent filings run from 2024-10-02 to 2025-04-01, with the modal transaction nature listed as option exercise; the buy and sell amounts in that sample are EUR 0 each.